Real-time enrollment status for this acute myelogenous leukemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:53 PM UTC
| NCT Number | NCT07566377 |
| Recruiting Status | Recruiting |
| Condition | Acute Myelogenous Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 71 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of July 17, 2026: Clinical trial NCT07566377 is currently recruiting participants. This phase2 study for acute myelogenous leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07566377 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07566377 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.